| PTSD |
Post-Traumatic Stress Disorder |
| GWAS |
Genome-Wide Association Studies |
| LD |
Linkage Disequilibrium |
| PGx |
Pharmacogenomics |
| RDS |
Reward Deficiency Syndrome |
| PBM |
Precision Behavioral Management |
| SUD |
Substance Use Disorder |
| NIDA |
National Institute on Drug Abuse |
| GABA |
Gamma-aminobutyric acid |
| CUD |
Cocaine Use Disorder |
| AUD |
Alcohol Use Disorder |
| ADHD |
Attention-Deficit/Hyperactivity Disorder |
| DMN |
Default Mode Network |
| GARS |
Genetic Addiction Risk Score |
| CNS |
Central Nervous System |
| SCID |
Severe Combined Immunodeficiency |
| CRF |
Corticotropin-releasing factor |
| POMC |
Proopiomelanocortin |
| EOP |
Endogenous Opiate Peptides |
| ACTH |
Adrenocorticotropic Hormone |
| ConA |
Concanavalin A |
| IBD |
Irritable Bowel Disorder |
| rsfMRI |
resting-state Functional Magnetic Resonance Imagining |
| LGMM |
Latent Growth Mixture Modeling |
| NE |
Norepinephrine |
| DOD |
Department of Defense |
| CISM |
Critical Incident Stress Management |
| WHO |
World Health Organization |
| ORs |
Odds Ratios |
| CIs |
Confidence Intervals |
| SE |
Standard Error |
| QQ |
Quantile–Quantile |
| PIP |
Posterior Inclusion Probability |